Evidence map›Paper›PMID 29994967›Full record

ArticleMenopause (New York, N.Y.)2018

Postmenopausal hormone treatment alters neural pathways but does not improve verbal cognitive function.

Alison Berent-Spillson, Angela S Kelley, Carol C Persad, Tiffany Love, Kirk A Frey, Nancy E Reame, Robert Koeppe, Jon-Kar Zubieta, Yolanda R Smith

Abstract read
In one paragraph

Article in Menopause (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alison Berent-SpillsonUniversity of Michigan, Ann Arbor, MI.
Angela S KelleyUniversity of Michigan, Ann Arbor, MI.
Carol C PersadUniversity of Michigan, Ann Arbor, MI.
Tiffany LoveUniversity of Utah, Salt Lake City, UT.
Kirk A FreyUniversity of Michigan, Ann Arbor, MI.
Nancy E ReameColumbia University, New York City, NY.
Robert KoeppeUniversity of Michigan, Ann Arbor, MI.
Jon-Kar ZubietaUniversity of Utah, Salt Lake City, UT.
Yolanda R SmithUniversity of Michigan, Ann Arbor, MI.

Funding

Neurobiology of the Menopausal TransitionR01AG027675 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, YOLANDA R · 2006 to 2010
$1.3M
Endogenous opioid activity and affective state in insulin resistant womenK01MH095920 · NIMH · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERENT-SPILLSON, ALISON RENEE · 2013 to 2017
$707k
NEUROBIOLOGICAL EFFECT OF LONG-TERM ESTROGEN REPLACEMENTK23RR017043 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SMITH, YOLANDA R · 2002 to 2006
$672k
NCRR NIH HHS K23 RR017043NIA NIH HHS R01 AG027675NIMH NIH HHS K01 MH095920
6 · The paper itself

Abstract

objectiveCognitive outcomes in trials of postmenopausal hormone treatment have been inconsistent. Differing outcomes may be attributed to hormone formulation, treatment duration and timing, and differential cognitive domain effects. We previously demonstrated treatment benefits on visual cognitive function. In the present study, we describe the effects of hormone treatment on verbal outcomes in the same women, seeking to understand the effects of prior versus current hormone treatment on verbal function.

methodsThis is a cross-sectional evaluation of 57 women (38 hormone users [25 prior long-term users and 13 current users] and 19 never-users). Hormone users took identical formulations of estrogen or estrogen + progestin (0.625 mg/d conjugated equine estrogens with or without medroxyprogesterone acetate) for at least 10 years, beginning within 2 years of menopause. Women were evaluated with tests of verbal function and functional magnetic resonance imaging (fMRI) of a verbal discrimination task.

resultsAll women scored similarly on assessments of verbal function (Hopkins Verbal Learning Test and a verbal discrimination task performed during the fMRI scanning session); however, women ever treated with hormones had more left inferior frontal (T = 3.72; P < 0.001) and right prefrontal cortex (T = 3.53; P < 0.001) activation during the verbal task. Hormone-treated women performed slightly worse on the verbal discrimination task (mean accuracy 81.72 ± 11.57 ever-treated, 85.30 ± 5.87 never-treated, P = 0.14), took longer to respond (mean reaction time 1.10 ± 0.17 s ever-treated, 1.02 ± 0.11 never-treated, P = 0.03), and remembered fewer previously viewed words (mean accuracy 62.21 ± 8.73 ever-treated, 65.45 ± 7.49 never-treated, P = 0.18). Increased posterior cingulate activity was associated with longer response times (R = 0.323, P = 0.015) and worse delayed verbal recall (R = -0.328, P = 0.048), suggesting that increased activation was associated with less efficient cognitive processing. We did not detect between group differences in activation in the left prefrontal cortex, superior frontal cortex, thalamus, or occipital/parietal junction.

conclusionsAlthough current and past hormone treatment was associated with differences in neural pathways used during verbal discrimination, verbal function was not higher than never-users.

Indexed as

AgedCognitionCross-Sectional StudiesDrug CombinationsEstrogen Receptor ModulatorsEstrogen Replacement TherapyEstrogensEstrogens, Conjugated (USP)FemaleHumansMagnetic Resonance ImagingMedroxyprogesterone AcetateMemory, Short-TermMental RecallMiddle AgedNeural PathwaysDrug CombinationsEstrogen Receptor ModulatorsEstrogensEstrogens, Conjugated (USP)Medroxyprogesterone AcetatePrempro

Identifiers

PMID29994967
PMCPMC6265072

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.